Slowey McManus Announces Acquisition
of Emerging BioCommunications PR Firm
(Boston) January 4, 2022 – Slowey McManus Communications (SMC) today announced it has acquired Emerging BioCommunications, a boutique strategic public relations firm specializing in life sciences companies and organizations. The founder of Emerging BioCommunications, Jeff Krasner, will join SMC as a Senior Vice President and Leader of the Life Sciences Group.
The acquisition adds a number of well-positioned new life science clients to SMC’s growing roster of clients and boosts the firm’s profile in the industry as an experienced partner with a full range of branding, messaging and digital communications tools.
“I’ve been working with Slowey McManus for several years now and I’m delighted to be joining the firm full-time as we continue to build on our success representing both well-established and promising new biotech and life science companies, said Krasner. “This combination presents a great opportunity for us to expand the services and capabilities we can offer during an unprecedented moment for the healthcare industry.”
Krasner, a former journalist who covered biotechnology and financial services for The Boston Globe and general business news for the Wall Street Journal for 20 years, has been working as a consultant for biotech companies and venture capital firms for the past 10 years.
“We are thrilled that Jeff has decided to join Slowey McManus, said Jim McManus, Principal Partner. “He is the best in the business for helping publicly traded and emerging life sciences companies communicate with key audiences for corporate launches, product introductions and major developments. His expertise in positioning and messaging, branding and visual assets creation will be a major boost for us as we expand this part of our business.”
SMC represents life science and healthcare clients in New England, across the US and throughout the world.
For more information, visit our website at www.sloweymcmanus.com